Solésence to restate 10 periods of financials over inventory cost accounting errors
Solésence said on August 17, 2026 that its previously issued financial statements from December 31, 2023 through March 31, 2026 should no longer be relied upon and must be restated. The errors involved how labor and overhead were allocated to inventory, which overstated inventories and misstated cost of revenue, and the filing says the errors also affected gross profit, net income (loss), earnings per share and stockholders' equity.
Key points
- Ten periods are affected, from December 31, 2023 through March 31, 2026, per the Audit Committee, Board and executive officers' August 17, 2026 conclusion.
- The errors relate to labor and overhead allocation in inventories, which the company says did not comply with ASC 330 inventory-costing requirements.
- The company expects to amend its 10-K reports for 2023, 2024 and 2025 and several 10-Q reports in the coming weeks.
- The 8-K is dated August 20, 2026, and was signed by CFO Laura Riffner; the Audit Committee discussed the matters with its independent accountant.
The filing
Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 21, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.